Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 26;16(5):945.
doi: 10.3390/cancers16050945.

A Retrospective Analysis from Western Romania Comparing the Treatment and Survivability of p16-Positive versus p16-Negative Oropharyngeal Cancer

Affiliations

A Retrospective Analysis from Western Romania Comparing the Treatment and Survivability of p16-Positive versus p16-Negative Oropharyngeal Cancer

Alexandru Chioreanu et al. Cancers (Basel). .

Abstract

Background: Oropharyngeal cancer is a global health concern due to its multifaceted nature. Recent molecular studies have linked p16 overexpression, associated with the human papillomavirus, to oropharyngeal cancer and its prognostic implications.

Materials and methods: This retrospective study in Western Romania examined 60 patients, categorizing them based on p16 biomarker status: 28 were p16 positive, and 32 were p16 negative. Statistical tests, including Fisher's exact and chi2, were used for analysis.

Results: Patients with p16-positive oropharyngeal cancer exhibited a better prognosis (3-year survival, p = 0.0477; midtreatment, p = 0.0349) and reported lower alcohol (p = 0.0046) and tobacco (p < 0.0001) use.

Conclusions: The study highlights the importance of p16 testing in oropharyngeal carcinoma diagnosis. It suggests modifying treatment approaches based on p16 status and underscores the differing prognoses associated with p16-positive and p16-negative cases.

Keywords: HPV; oropharyngeal cell carcinoma; p16 overexpression; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Results of the Kaplan–Meier survival analysis.

References

    1. Sitaru A.M., Flondor D., Dinu Ş., Horhat I.D., Iftode O.A., Poenaru M., Balica N.C., Baderca F., Georgescu D., Chioran D., et al. Laryngeal malignancies—Epidemiological data and particularities of the cases diagnosed in Western Romania (October 2016–July 2020) Rom. J. Morphol. Embryol. 2022;63:153–160. doi: 10.47162/RJME.63.1.16. - DOI - PMC - PubMed
    1. Melchers L.J., Mastik M.F., Cameron B.S., Dijk B.A.C.V., De Bock G.H., Laan B.F.A.M.V.D., Van Der Vegt B., Speel E.J.M., Roodenburg J.L.N., Witjes M.J.H., et al. Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: More than meets the eye. Br. J. Cancer. 2015;112:1349–1357. doi: 10.1038/bjc.2015.99. - DOI - PMC - PubMed
    1. Ndiaye C., Mena M., Alemany L., Arbyn M., Castellsagué X., Laporte L., Bosch F.X., de Sanjosé S., Trottier H. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: A systematic review and meta-analysis. Lancet Oncol. 2014;15:1319–1331. doi: 10.1016/S1470-2045(14)70471-1. - DOI - PubMed
    1. Mogoantă C.A., Ciolofan M.S., Istrate-Ofițeru A.M., Mogoantă S.Ș., Roșu G.C., Anghelina F., Iovănescu G. HPV and Other Risk Factors Involved in Pharyngeal Neoplasm—Clinical and Morphopathological Correlations in the Southwestern Region of Romania. Pathogens. 2023;12:984. doi: 10.3390/pathogens12080984. - DOI - PMC - PubMed
    1. Pytynia K.B., Dahlstrom K.R., Sturgis E.M. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014;50:380–386. doi: 10.1016/j.oraloncology.2013.12.019. - DOI - PMC - PubMed

LinkOut - more resources